BioSpace News Archive

Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report financial results for the third quarter of fiscal year 2022, the period ended May 31, 2022, after the close of the financial markets on Wednesday, July 6, 2022.b

Danaher Corporation announced that it will webcast its quarterly earnings conference call for the second quarter 2022 on Thursday, July 21, 2022 beginning at 8:00 a.m. ET and lasting approximately 1 hour.

The Lausanne-based team of US investment firm, +ND Capital, today marked its second successful exit in the European biotechnology market as Belgian biotech company, Galapagos NV (Euronext & NASDAQ: GLPG), announced1 that it will acquire Dutch cell therapy company CellPoint. +ND Capital was the sole venture investor in CellPoint, a company dedicated to developing CAR-T therapies at the point-of-care.

Rakuten Medical Taiwan, Inc. announced that their ASP-1929 Photoimmunotherapy Phase 2 clinical trial has enrolled and treated its first patient.

The latest market analysis report published by Reports and Data, titled ‘Global Ultrasound Systems Market – Forecast to 2028,’ thoroughly examines the Ultrasound Systems industry to provide essential data & information for the targeted readers

The latest market analysis report published by Reports and Data, titled ‘Global Urology Instrument Market – Forecast to 2028,’ thoroughly examines the Urology Instrument industry to provide essential data & information for the targeted readers.

Rising prevalence of acute and chronic diseases across the globe, increasing demand for biologics and biosimilars, and rising investments for developing advanced and effective syringes are some key factors expected to drive global Prefilled Syringes market growth.

Inspired Spine reached the milestone of completing 1,500 Oblique Lateral Lumbar Interbody Fusion (OLLIF) procedures.

BlueAllele® Corporation, a biotechnology company focused on advancing transformational gene correction technologies, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,365,407 (the ‘407 Patent) related to its proprietary in vivo gene correction methodologies.

According to Nova one advisor, the U.S. Skilled Nursing Facility market size was valued at US$ 175.12 billion in 2021 and is expected to hit US$ 232.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 3.35% from 2022 to 2030.